Injection of AAV-miR-23a/27a/24-2 in mice with muscle atrophy induced by chronic kidney disease (CKD) could increase phosphorylation of Akt and FoxO and reduce muscle loss, meanwhile increasing grip strength and, interestingly, inhibiting PTEN expression [35]. The gene discussed is AKT1; the disease is chronic kidney disease.